人工智能对抗成药物发现的方法
Dong Chen1, Jian Jiang1,2, Nicole Hayes1
1Department of Mathematics, Michigan State University MI 48824 USA weig@msu.edu.
概括
人工智能 (AI) 通过精确地准与成有关的关键大脑系统,加速了对抗成药物的发现. 这种方法克服了传统的局限性,为更有效的成治疗铺平了道路.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 人工智能的人工智能
背景情况:
- 药物成是一个主要的公共卫生问题,传统药物发现进展缓慢.
- 现有的治疗方法在有效性和针对复杂的神经化学途径方面存在局限性.
研究的目的:
- 审查人工智能 (AI) 在开发新型抗成药物的作用.
- 探索AI在毒中针对阿片类,多巴胺和GABAergic系统的应用.
- 为了确定人工智能驱动的成研究的未来趋势.
主要方法:
- 审查当前关于AI应用在药物发现中的文献.
- 分析人工智能在向与成有关的特定神经递质系统中的作用.
- 探索新兴的人工智能技术,用于更广泛的成相关研究.
主要成果:
- 人工智能显著提高了抗成药物开发的速度和精度.
- 人工智能促进了关键神经化学系统 (如阿片类药物,多巴胺和GABAergic通路) 中的有针对性的干预.
- 人工智能已经准备好启动对不太了解的成相关系统的研究.
结论:
- 人工智能是克服传统抗成药物发现局限性的变革性工具.
- 人工智能整合有望加速开发更优质,更有针对性的成治疗方法.
- 未来的研究方向包括利用人工智能用于新药发现技术在成治疗.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
448
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
448
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug Dependence
989
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
989
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
110
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110


